1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
Breast Biopsy Devices Market - Global Market Size, Share, Development, Growth and Demand Forecast, 2013 - 2023

Breast Biopsy Devices Market - Global Market Size, Share, Development, Growth and Demand Forecast, 2013 - 2023

  • February 2018
  • 143 pages
  • ID: 5380701
  • Format: PDF
  • By Prescient & Strategic Intelligence Private Limited

Summary

Table of Contents

The growth is mainly led by product and technological innovations, increasing incidence of breast cancer cases, rising propensity for minimally invasive surgeries, and mounting number of breast cancer screening programs.

Insights on market segments
On the basis of the procedure conducted for breast biopsy, the market is categorized into vacuum-assisted, core needle, fine needle aspiration, and surgical biopsy. Vacuum-assisted biopsies have been accounting for the largest share in the breast biopsy devices market till now. It is also expected to be the fastest growing category during the forecast period. This can be mainly attributed to its various advantages, such as its ability to precisely locate the area of abnormality using imaging guidance, so that samples are removed only from the region of interest.

On the basis of product, the breast biopsy devices market has been segmented into guidance systems, biopsy needles/guns, biopsy tables, biopsy wires, and other products. Guidance systems are estimated to hold the largest share of 40.1%, in the market in 2017, with its demand majorly driven by the availability of stereotactic breast biopsy and tomosynthesis options in a single system, and the requirement of these systems in all types of surgeries.

Different types of imaging modalities are used while performing breast biopsy procedure, such as mammography guided stereotactic biopsy, ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), and several others. Among these, Mammography guided stereotactic biopsy has been holding the largest share in the breast biopsy devices market till now, as it is a minimally invasive procedure and the needle used does not distort the breast tissue. However, ultrasound guided biopsy is expected to be the fastest growing imaging modality during the forecast period.

Hospitals, diagnostic centers, and other healthcare providers constitute the end-user base in the breast biopsy devices market. Diagnostic centers have been the largest end user in the breast biopsy devices market till now. However, as hospitals are witnessing increasing demand for advanced healthcare facilities and growing healthcare infrastructure, the category is expected to be the fastest growing end-user during the forecast period.

APAC to be the fastest growing market for breast biopsy devices
During the forecast period, the breast biopsy devices industry is expected to witness the fastest growth in in Asia-Pacific (APAC), owing to growing geriatric population, increasing prevalence of breast cancer, growing awareness about breast cancer, rising healthcare expenditure, per capita income, and increasing research in breast biopsy devices in the region. According to National Institute of Cancer Prevention and Research, breast cancer is the most common cancer in women in India and accounts for about a quarter of all cancers in women in Indian cities, and the average age for breast cancer in India is almost a decade lower than that in the West.

According to International Agency for Research on Cancer, in 2012, breast cancer incidences reported in India were 144,937 and the mortality rate in women in India was 70,218, which is comparatively higher than China (47,989). In order to balance these statistics, the government and several other organizations are also creating awareness about breast cancer. For instance, October has been designated as the breast cancer awareness month by the government of India, which is an annual campaign to educate people about breast cancer. Also, the Pink Initiative, a registered charity in Mumbai, creates awareness about breast cancer amongst women in India. These factors cumulatively lead to growth in the demand of breast biopsy devices in the region.

Breast biopsy surgeries are cheaper in India and they are also witnessing an increase in the research and development for the treatment of breast cancer, which is ultimately propelling the growth of the breast biopsy devices market in the region. For instance, a team of researchers from Tohoku University, in January 2016, developed a new method to detect breast cancer by combining a mammogram with an ultrasound in a procedure that appears to be more accurate than mammogram testing alone.

Key players launching new products for market expansion
Globally, key players in the breast biopsy devices industry are launching products to gain a larger market share. For instance, in November 2017, Siemens Healthineers, a subsidiary of Siemens AG, unveiled its new Mammomat Revelation imaging system at the 2017 Radiological Society of North America (RSNA) Annual Meeting in Chicago. 3D HD Breast Biopsy uses company’s 50-degree wide-angle HD breast tomosynthesis to obtain more targeted, accurate biopsies at a lower dose. The system also offers titanium contrast-enhanced mammography exams and automated breast density measurement.

In August 2017, Hologic Inc. announced the commercial availability of Brevera breast biopsy system with CorLumina imaging technology, in the U.S. The Brevera system provides clinicians with more information at the point of care and results in significant cost and time savings without compromising with accuracy or patient health outcomes.

Some of the other major players operating in the breast biopsy devices market include Danaher Corporation, Argon Medical Devices Inc., Becton, Dickinson and Company, Sterylab S.R.L., Scion Medical Technologies LLC, Planmed Oy, Medtronic plc, and Cook Medical LLC.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
North America Hereditary Cancer Testing Market to 2027 - Regional Analysis and Forecasts by Diagnosis Type; Technology; End User, and Country

North America Hereditary Cancer Testing Market to 2027 - Regional Analysis and Forecasts by Diagnosis Type; Technology; End User, and Country

  • $ 3000
  • October 2019

The North America hereditary cancer testing market is expected to reach US$ 3,247.37 Mn in 2027 from US$ 1,255.79 Mn in 2018. This market is projected to grow at a growth rate of 11.6% from 2019-2027.The ...

Global Smart Biopsy Market (2019-2025)

Global Smart Biopsy Market (2019-2025)

  • $ 3600
  • November 2019

The Global Smart Biopsy Market size is expected to reach $3.2 billion by 2025, rising at a market growth of 5.3% CAGR during the forecast period. A biopsy is referred to as the surgical removal of tissue ...

Neurodiagnostics Market by Product, Disease Pathology, End User And Region - Global Forecast to 2024

Neurodiagnostics Market by Product, Disease Pathology, End User And Region - Global Forecast to 2024

  • $ 4950
  • December 2019

The global neurodiagnostics market is projected to grow at a CAGR of 7.3% during the forecast period.The global neurodiagnostics market is expected to reach USD 8.4 billion by 2024 from USD 5.9 billion ...


ref:plp2018

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on